logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12490933 B1

PDFFull Text
Date of Patent:
Dec. 09, 2025

Filed:

Mar. 06, 2025

Treatment of depression using machine learning

Applicants:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Board of Regents, the University of Texas System, Austin, TX (US);

The United States Government As Represented BY the Department of Veterans Affairs, Washington, DC (US);

Inventors:

Amit Etkin, Palo Alto, CA (US);

Madhukar Trivedi, Dallas, TX (US);

Wei Wu, Palo Alto, CA (US);

Assignees:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Board of Regents, The University of Texas System, Austin, TX (US);

The United States Government as represented by the Department of Veterans Affairs, Washington, DC (US);

Attorney:

Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.

Primary Examiner:

Russell S Negin

Int. Cl.
CPC ...
G01N 33/48 (2006.01); A61B 5/00 (2006.01); A61B 5/16 (2006.01); A61B 5/245 (2021.01); A61B 5/374 (2021.01); A61B 5/377 (2021.01); G01N 33/50 (2006.01); G01R 33/48 (2006.01); G06N 20/00 (2019.01); G16H 30/20 (2018.01); G16H 30/40 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); A61N 1/36 (2006.01); A61N 1/38 (2006.01); A61N 2/00 (2006.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/70 (2018.01);
U.S. Cl.
CPC ...
A61B 5/4848 (2013.01); A61B 5/0075 (2013.01); A61B 5/165 (2013.01); A61B 5/168 (2013.01); A61B 5/245 (2021.01); A61B 5/374 (2021.01); A61B 5/377 (2021.01); A61B 5/4082 (2013.01); A61B 5/4088 (2013.01); A61B 5/7267 (2013.01); G01R 33/4806 (2013.01); G01R 33/4808 (2013.01); G06N 20/00 (2019.01); G16H 30/20 (2018.01); G16H 30/40 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/70 (2018.01); A61B 2562/0223 (2013.01); A61N 1/36053 (2013.01); A61N 1/38 (2013.01); A61N 2/006 (2013.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/70 (2018.01);
Abstract

Provided herein are, inter alia, methods for identifying subjects suffering from depression that will respond to treatment with an antidepressant.

Find Patent Forward Citations

Loading…